Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Comparison of human tissue microarray to human pericyte transcriptome yields novel perivascular cell markers.

Hsu C, Salazar MG, Miller S, Meyers C, Ding C, Hardy WR, Peault B, James AW.

Stem Cells Dev. 2019 Jul 2. doi: 10.1089/scd.2019.0106. [Epub ahead of print]

PMID:
31264500
2.

ShcA Adaptor Protein Promotes Nephrin Endocytosis and Is Upregulated in Proteinuric Nephropathies.

Martin CE, Petersen KA, Aoudjit L, Tilak M, Eremina V, Hardy WR, Quaggin SE, Takano T, Jones N.

J Am Soc Nephrol. 2018 Jan;29(1):92-103. doi: 10.1681/ASN.2017030285. Epub 2017 Oct 10.

3.

An Embryonic Stem Cell-Specific NuRD Complex Functions through Interaction with WDR5.

Ee LS, McCannell KN, Tang Y, Fernandes N, Hardy WR, Green MR, Chu F, Fazzio TG.

Stem Cell Reports. 2017 Jun 6;8(6):1488-1496. doi: 10.1016/j.stemcr.2017.04.020. Epub 2017 May 18.

4.

Isolation and characterization of canine perivascular stem/stromal cells for bone tissue engineering.

James AW, Zhang X, Crisan M, Hardy WR, Liang P, Meyers CA, Lobo S, Lagishetty V, Childers MK, Asatrian G, Ding C, Yen YH, Zou E, Ting K, Peault B, Soo C.

PLoS One. 2017 May 10;12(5):e0177308. doi: 10.1371/journal.pone.0177308. eCollection 2017.

5.

Transcriptional Networks in Single Perivascular Cells Sorted from Human Adipose Tissue Reveal a Hierarchy of Mesenchymal Stem Cells.

Hardy WR, Moldovan NI, Moldovan L, Livak KJ, Datta K, Goswami C, Corselli M, Traktuev DO, Murray IR, Péault B, March K.

Stem Cells. 2017 May;35(5):1273-1289. doi: 10.1002/stem.2599. Epub 2017 Mar 19.

6.

Perivascular Stem Cells Diminish Muscle Atrophy Following Massive Rotator Cuff Tears in a Small Animal Model.

Eliasberg CD, Dar A, Jensen AR, Murray IR, Hardy WR, Kowalski TJ, Garagozlo CA, Natsuhara KM, Khan AZ, McBride OJ, Cha PI, Kelley BV, Evseenko D, Feeley BT, McAllister DR, Péault B, Petrigliano FA.

J Bone Joint Surg Am. 2017 Feb 15;99(4):331-341. doi: 10.2106/JBJS.16.00645.

PMID:
28196035
7.

Prospective purification of perivascular presumptive mesenchymal stem cells from human adipose tissue: process optimization and cell population metrics across a large cohort of diverse demographics.

West CC, Hardy WR, Murray IR, James AW, Corselli M, Pang S, Black C, Lobo SE, Sukhija K, Liang P, Lagishetty V, Hay DC, March KL, Ting K, Soo C, Péault B.

Stem Cell Res Ther. 2016 Mar 30;7:47. doi: 10.1186/s13287-016-0302-7.

8.

A Role for MOSPD1 in Mesenchymal Stem Cell Proliferation and Differentiation.

Kara M, Axton RA, Jackson M, Ghaffari S, Buerger K, Watt AJ, Taylor AH, Orr B, Hardy WR, Peault B, Forrester LM.

Stem Cells. 2015 Oct;33(10):3077-86. doi: 10.1002/stem.2102. Epub 2015 Aug 14.

9.

Stem cell technology for bone regeneration: current status and potential applications.

Asatrian G, Pham D, Hardy WR, James AW, Peault B.

Stem Cells Cloning. 2015 Feb 10;8:39-48. doi: 10.2147/SCCAA.S48423. eCollection 2015. Review.

10.

Natural history of mesenchymal stem cells, from vessel walls to culture vessels.

Murray IR, West CC, Hardy WR, James AW, Park TS, Nguyen A, Tawonsawatruk T, Lazzari L, Soo C, Péault B.

Cell Mol Life Sci. 2014 Apr;71(8):1353-74. doi: 10.1007/s00018-013-1462-6. Epub 2013 Oct 25. Review.

PMID:
24158496
11.

Temporal regulation of EGF signalling networks by the scaffold protein Shc1.

Zheng Y, Zhang C, Croucher DR, Soliman MA, St-Denis N, Pasculescu A, Taylor L, Tate SA, Hardy WR, Colwill K, Dai AY, Bagshaw R, Dennis JW, Gingras AC, Daly RJ, Pawson T.

Nature. 2013 Jul 11;499(7457):166-71. doi: 10.1038/nature12308.

12.

The ShcA PTB domain functions as a biological sensor of phosphotyrosine signaling during breast cancer progression.

Ahn R, Sabourin V, Ha JR, Cory S, Maric G, Im YK, Hardy WR, Zhao H, Park M, Hallett M, Siegel PM, Pawson T, Ursini-Siegel J.

Cancer Res. 2013 Jul 15;73(14):4521-32. doi: 10.1158/0008-5472.CAN-12-4178. Epub 2013 May 21.

13.

Distinct phosphotyrosine-dependent functions of the ShcA adaptor protein are required for transforming growth factor β (TGFβ)-induced breast cancer cell migration, invasion, and metastasis.

Northey JJ, Dong Z, Ngan E, Kaplan A, Hardy WR, Pawson T, Siegel PM.

J Biol Chem. 2013 Feb 15;288(7):5210-22. doi: 10.1074/jbc.M112.424804. Epub 2012 Dec 31.

14.

The adaptor protein Grb2 is not essential for the establishment of the glomerular filtration barrier.

Bisson N, Ruston J, Jeansson M, Vanderlaan R, Hardy WR, Du J, Hussein SM, Coward RJ, Quaggin SE, Pawson T.

PLoS One. 2012;7(11):e50996. doi: 10.1371/journal.pone.0050996. Epub 2012 Nov 30.

15.

STR melting curve analysis as a genetic screening tool for crime scene samples.

Nguyen Q, McKinney J, Johnson DJ, Roberts KA, Hardy WR.

J Forensic Sci. 2012 Jul;57(4):887-99. doi: 10.1111/j.1556-4029.2012.02106.x. Epub 2012 Apr 6.

PMID:
22486563
16.

The ShcA SH2 domain engages a 14-3-3/PI3'K signaling complex and promotes breast cancer cell survival.

Ursini-Siegel J, Hardy WR, Zheng Y, Ling C, Zuo D, Zhang C, Podmore L, Pawson T, Muller WJ.

Oncogene. 2012 Nov 29;31(48):5038-44. doi: 10.1038/onc.2012.4. Epub 2012 Jan 30.

PMID:
22286768
17.

The ShcA phosphotyrosine docking protein uses distinct mechanisms to regulate myocyte and global heart function.

Vanderlaan RD, Hardy WR, Kabir MG, Pasculescu A, Jones N, deTombe PP, Backx PH, Pawson T.

Circ Res. 2011 Jan 21;108(2):184-93. doi: 10.1161/CIRCRESAHA.110.233924. Epub 2010 Dec 9.

18.

Receptor tyrosine kinase signaling favors a protumorigenic state in breast cancer cells by inhibiting the adaptive immune response.

Ursini-Siegel J, Cory S, Zuo D, Hardy WR, Rexhepaj E, Lam S, Schade B, Jirstrom K, Bjur E, Piccirillo CA, Denardo D, Coussens LM, Brennan DJ, Gallagher WM, Park M, Pawson T, Hallett M, Muller WJ.

Cancer Res. 2010 Oct 15;70(20):7776-87. doi: 10.1158/0008-5472.CAN-10-2229. Epub 2010 Oct 5.

19.

The PTB domain of ShcA couples receptor activation to the cytoskeletal regulator IQGAP1.

Smith MJ, Hardy WR, Li GY, Goudreault M, Hersch S, Metalnikov P, Starostine A, Pawson T, Ikura M.

EMBO J. 2010 Mar 3;29(5):884-96. doi: 10.1038/emboj.2009.399. Epub 2010 Jan 14.

20.

UNC-129 regulates the balance between UNC-40 dependent and independent UNC-5 signaling pathways.

MacNeil LT, Hardy WR, Pawson T, Wrana JL, Culotti JG.

Nat Neurosci. 2009 Feb;12(2):150-5. doi: 10.1038/nn.2256. Epub 2009 Jan 25.

21.

ShcA signalling is essential for tumour progression in mouse models of human breast cancer.

Ursini-Siegel J, Hardy WR, Zuo D, Lam SH, Sanguin-Gendreau V, Cardiff RD, Pawson T, Muller WJ.

EMBO J. 2008 Mar 19;27(6):910-20. doi: 10.1038/emboj.2008.22. Epub 2008 Feb 14.

22.

Combinatorial ShcA docking interactions support diversity in tissue morphogenesis.

Hardy WR, Li L, Wang Z, Sedy J, Fawcett J, Frank E, Kucera J, Pawson T.

Science. 2007 Jul 13;317(5835):251-6.

23.

Analysis of a Shc family adaptor protein, ShcD/Shc4, that associates with muscle-specific kinase.

Jones N, Hardy WR, Friese MB, Jorgensen C, Smith MJ, Woody NM, Burden SJ, Pawson T.

Mol Cell Biol. 2007 Jul;27(13):4759-73. Epub 2007 Apr 23.

24.

Screening for PTB domain binding partners and ligand specificity using proteome-derived NPXY peptide arrays.

Smith MJ, Hardy WR, Murphy JM, Jones N, Pawson T.

Mol Cell Biol. 2006 Nov;26(22):8461-74. Epub 2006 Sep 18. Erratum in: Mol Cell Biol. 2007 Jun;27(12):4601.

25.

Modification of the Creator recombination system for proteomics applications--improved expression by addition of splice sites.

Colwill K, Wells CD, Elder K, Goudreault M, Hersi K, Kulkarni S, Hardy WR, Pawson T, Morin GB.

BMC Biotechnol. 2006 Mar 6;6:13.

26.

Modulation of Erbb2 signaling during development: a threshold level of Erbb2 signaling is required for development.

Chan R, Hardy WR, Dankort D, Laing MA, Muller WJ.

Development. 2004 Nov;131(22):5551-60. Epub 2004 Oct 20.

27.

Germ-line expression of an oncogenic erbB2 allele confers resistance to erbB2-induced mammary tumorigenesis.

Andrechek ER, Hardy WR, Laing MA, Muller WJ.

Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4984-9. Epub 2004 Mar 29.

28.

ErbB2 is required for muscle spindle and myoblast cell survival.

Andrechek ER, Hardy WR, Girgis-Gabardo AA, Perry RL, Butler R, Graham FL, Kahn RC, Rudnicki MA, Muller WJ.

Mol Cell Biol. 2002 Jul;22(13):4714-22.

29.

Penetration of the chest by less-than-lethal "beanbag" shotgun rounds.

Wawro PA, Hardy WR.

J Trauma. 2002 Apr;52(4):767-8. No abstract available.

PMID:
11956399
30.

The catalytic activity of the ErbB-2 receptor tyrosine kinase is essential for embryonic development.

Chan R, Hardy WR, Laing MA, Hardy SE, Muller WJ.

Mol Cell Biol. 2002 Feb;22(4):1073-8.

31.

Mammary gland neoplasia: insights from transgenic mouse models.

Siegel PM, Hardy WR, Muller WJ.

Bioessays. 2000 Jun;22(6):554-63. Review.

PMID:
10842309
32.

Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis.

Andrechek ER, Hardy WR, Siegel PM, Rudnicki MA, Cardiff RD, Muller WJ.

Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3444-9.

33.

Strain-dependent myeloid hyperplasia, growth deficiency, and accelerated cell cycle in mice lacking the Rb-related p107 gene.

LeCouter JE, Kablar B, Hardy WR, Ying C, Megeney LA, May LL, Rudnicki MA.

Mol Cell Biol. 1998 Dec;18(12):7455-65.

34.
35.

Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors.

Siegel PM, Dankort DL, Hardy WR, Muller WJ.

Mol Cell Biol. 1994 Nov;14(11):7068-77.

36.

Phosphorylation of Sindbis virus nsP3 in vivo and in vitro.

Li GP, La Starza MW, Hardy WR, Strauss JH, Rice CM.

Virology. 1990 Nov;179(1):416-27.

PMID:
2145690
38.

Synthesis and processing of the nonstructural polyproteins of several temperature-sensitive mutants of Sindbis virus.

Hardy WR, Hahn YS, de Groot RJ, Strauss EG, Strauss JH.

Virology. 1990 Jul;177(1):199-208.

PMID:
2141204
41.

Three-way reciprocal chromosomal translocation in an acute lymphoblastic leukemia patient with hypereosinophilia syndrome.

McConnell TS, Foucar K, Hardy WR, Saiki J.

J Clin Oncol. 1987 Dec;5(12):2042-4. No abstract available.

PMID:
3479532
42.

Computed tomography scanning after chymopapain injection for herniated nucleus pulposus. A prospective study.

Boumphrey FR, Bell GR, Modic M, Powers DF, Hardy WR.

Clin Orthop Relat Res. 1987 Jun;(219):120-3.

PMID:
3581560
43.

Transection of the thoracic aorta: assessment of a trauma system.

Hartford JM, Fayer RL, Shaver TE, Thompson WM, Hardy WR, Roys GD, Murdock MA, Gazzaniga AB.

Am J Surg. 1986 Feb;151(2):224-9.

PMID:
3946756
44.

Acquired methemoglobinemia and hemolytic anemia after usual doses of phenazopyridine.

Jeffery WH, Zelicoff AP, Hardy WR.

Drug Intell Clin Pharm. 1982 Feb;16(2):157-9.

PMID:
7075467
45.

Loss of warfarin effect after occupational insecticide exposure.

Jeffery WH, Ahlin TA, Goren C, Hardy WR.

JAMA. 1976 Dec 20;236(25):2881-2. No abstract available.

PMID:
62851
46.

Multiple myeloma and benign monoclonal gammopathy: differentiation by immunofluorescence of lymphocytes.

Lindström FD, Hardy WR, Eberle BJ, Williams RC Jr.

Ann Intern Med. 1973 Jun;78(6):837-44. No abstract available.

PMID:
4123388
47.

An approach to anemia.

Hardy WR, Saiki JH, Simon ER.

Rocky Mt Med J. 1970 Nov;67(11):29-36. No abstract available.

PMID:
5480534
48.

Hypereosinophilia.

Anderson RE, Hardy WR.

Ann Intern Med. 1968 Dec;69(6):1331-2. No abstract available.

PMID:
5725748
49.

The hypereosinophilic syndromes.

Hardy WR, Anderson RE.

Ann Intern Med. 1968 Jun;68(6):1220-9. No abstract available.

PMID:
5653621
50.

HEREDITARY METHEMOGLOBINEMIA DUE TO DIAPHORASE DEFICIENCY IN NAVAJO INDIANS.

BALSAMO P, HARDY WR, SCOTT EM.

J Pediatr. 1964 Dec;65:928-31. No abstract available.

PMID:
14244100

Supplemental Content

Loading ...
Support Center